Innoheart Pte Ltd
Asia’s 1st & only GLP Med Device pre-clinical CRO offering high value svcs in a cost efficient, IP protected & research friendly country.
Innoheart is Asia's first certified Good Laboratory Practice (GLP) medical device pre-clinical contract research organization (CRO), providing in-life pre-clinical studies to academic & research institutions, hospitals and medical device companies for evaluating complex medical devices (eg. coronary and peripheral stents), biologics (eg. cell therapy for regenerative medicine) and medical and endovascular implants (eg. pacemakers).